AGA Medical Inc. enrolls first subjest in clinical trial of cardiac device for preventing strokes in patients with abnormal heartbeats.

AGA Medical Inc. (NSDQ:AGAM) enrolled the first patient in a clinical trial of a cardiac device aimed at preventing strokes in patients with abnormal heartbeats.
CEO John Barr called the first enrollment in the company’s Amplatzer Cardiac Plug trial “a significant milestone” for the company, according to a statement from AGA.
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
If you read nothing else today, make sure you're still in the know with MassDevice +3.
The FDA's Orthopedic & Rehabilitations Devices Panel agrees with the FDA's recommendations that...